A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Var2 Pharmaceuticals
Valo Therapeutics Oy
NextPoint Therapeutics, Inc.
BioEclipse Therapeutics
Innovent Biologics (Suzhou) Co. Ltd.
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Celgene
Novartis
Valerio Therapeutics
Valerio Therapeutics
INSYS Therapeutics Inc
Alaunos Therapeutics